BEAM CIK: 1745999

Beam Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−392
FY22:
−338
FY23:
−176
FY24:
−416
FY25:
−384
(positive)
Change from FY21 to FY25
millions USD
FY21:
−407
FY22:
−387
FY23:
−155
FY24:
−374
FY25:
−366
(positive)
Change from FY21 to FY25
millions USD
FY21:
−371
FY22:
−260
FY23:
−131
FY24:
−377
FY25:
−80.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−371
FY22:
−289
FY23:
−133
FY24:
−377
FY25:
−80.0

All amounts in millions USD Data sources:SEC EDGARTwelve Data